Cure My Disease

Don't miss your cure!

 Log in / Sign up

Which dry needling method best eases jaw pain? a Head-to-Head trial

NCT ID NCT07706153

Symptom relief Sponsor: Flávio Magno Gonçalves Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 15, 2026 · Last updated Jul 24, 2026 · Updated 3 times

Summary

This trial tests three dry needling methods—dynamic, static, and a mix—for treating orofacial myofascial pain, a common jaw muscle condition. Forty-five adults with active trigger points in their chewing muscles will receive one technique. The study measures pain intensity, pressure tolerance, jaw movement, and comfort over two weeks to find the most effective and tolerable approach.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
dry needling therapy
What this could lead to
If successful, this could help standardize a more effective and comfortable dry needling protocol for treating orofacial pain.
What could go wrong
This is a small, early-phase trial with only 45 participants, so results may not apply broadly. Different techniques may show similar effectiveness.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 45 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Aug 2026

An estimate. Start dates often move.

Expected to finish

Apr 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Clinical diagnosis of Myofascial Pain (with or without referred pain) in the masseter and/or temporalis muscles according to the Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) Axis I * Presence of at least one active trigger point in a taut band reproducing the chief complaint * Baseline pain intensity ≥ 2 on the VAS in the last two weeks * Confirmed pressure pain threshold (PPT ≤ 1.5 kg/cm²) * Signed informed consent form Exclusion Criteria: * TMD treatment in the last 3 months (physical therapy, needling, laser therapy) or Botulinum Toxin injection in the orofacial region within 12 months * Continuous systemic use of analgesics, anti-inflammatories, or muscle relaxants * Diagnosis of fibromyalgia, systemic rheumatic diseases, neurological disorders, or neuropathic pain * Needle phobia (belonephobia), coagulation disorders, or use of anticoagulant drugs * Active skin or odontogenic infections in the application area * History of recent facial trauma or orthognathic/joint surgery * Pregnancy

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Facial pain are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

facial neuralgia Facial Pain myofascial pain syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Facial pain Myofascial pain syndromes Trigger points

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Center for Diagnosis and Treatment of the Temporomandibular Joint, Universidade Tuiuti do Paraná (CDATM-UTP)

    Curitiba, Paraná, 80430140, Brazil

More trials for these conditions

Other studies related to the condition(s) this trial covers.